510(k) K260301
K260301 is an FDA 510(k) premarket notification submitted by Hangzhou Qiantang Longyue Biotechnology Co., Ltd. for the device "Vial Adapter". The FDA issued a decision of Substantially Equivalent on Jun 5, 2026. The device falls under product code LHI (Set, I.V. Fluid Transfer), a Class II device regulated under 21 CFR 880.5440. Hangzhou Qiantang Longyue Biotechnology Co., Ltd. has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 5, 2026
- Date Received
- Jan 30, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Set, I.V. Fluid Transfer
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type
- 510(k)
Need the full FDA record for Hangzhou Qiantang Longyue Biotechnology Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.